Summary by Futu AI
SeaStar Medical Holding Corporation, a Delaware-based company, has filed a registration statement with the Securities and Exchange Commission (SEC) on August 2, 2024, for a Form S-3 registration. This filing pertains to the potential sale of up to 1,014,219 shares of common stock by certain selling securityholders. These shares are issuable upon the exercise of previously issued warrants. The registration allows these securityholders to resell their shares in the public market. SeaStar Medical will not receive any proceeds from the sale of these shares, but will receive the exercise price of the warrants unless they are exercised on a cashless basis. The company will bear all expenses related to the registration of the shares. The selling securityholders may sell their shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The registration statement also includes indemnification agreements for directors and officers, and details on the legal and accounting costs associated with the registration.
